OpenVSafe by OpenVAERS
Search V-safe

YPS-34012-76918

3 vaccinations 3 coded responses 11 check-ins 3 free-text entries 3 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
981 / WA
Registered
2021-12-12
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-26
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-16
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-12
    Registered in v-safe
  4. 2021-12-12
    Dose 3 — Pfizer-BioNTech
  5. 2021-12-12
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  6. 2021-12-13
    Survey response — days 1–6 daily, dose 3
    MedDRA: Cough, Eye pain, Nasal congestion, Rhinorrhoea — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: Eye pain, cough, runny nose/congestion
    MedDRA releases: 2024-11 · check-in free text available
  7. 2021-12-13
    Report sent to call center — days 1–6 daily, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  8. 2021-12-14
    Survey response — days 1–6 daily, dose 3
    MedDRA: Cough, Eye pain — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Eye pain, mild cough
    MedDRA releases: 2024-11 · check-in free text available
  9. 2021-12-14
    Report sent to call center — days 1–6 daily, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  10. 2021-12-14
  11. 2021-12-15
  12. 2021-12-16
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  13. 2021-12-19
    Health check-in — day 7, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  14. 2021-12-26
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  15. 2022-01-02
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  16. 2022-01-09
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  17. 2022-01-16
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  18. 2022-01-23
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  19. 2022-12-12
    Survey response — 12 months, dose 3
    MedDRA: Respiratory syncytial virus infection, Streptococcal infection, Viral infection — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: RSV, additional viral illness, and strep
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-12-12
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  21. 2022-12-13
  22. 2022-12-13
  23. 2022-12-13

Vaccinations

DoseDateManufacturerCo-administered
12020-12-26Pfizer-BioNTech No
22021-01-16Pfizer-BioNTech No
32021-12-12Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-12-13 Unsuccessful
2021-12-14 Unsuccessful
2022-12-12 Unsuccessful

Free text

Release 10 — days 1–6 daily, dose 3

2021-12-13

Systemic reaction (other): Eye pain, cough, runny nose/congestion

2021-12-14

Systemic reaction (other): Eye pain, mild cough

Release 12 — 12 months, dose 3

2022-12-12

Symptoms: RSV, additional viral illness, and strep

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDRespiratory syncytial virus infection · · ✓
SDStreptococcal infection · · ✓
SDViral infection · · ✓
SROCough · · ✓
SROEye pain · · ✓
SRONasal congestion · · ✓
SRORhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…